Sort
326,823 grants matching “clinical trial”
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$3,214,328Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
CORAL: Clinical Coordinating Center
$3,214,285Christopher J Cooper · University Of Toledo Health Sci Campus · U01 · FY2006 · HL
PROGRAM PROJECT GRANT: Molecular Targets of Germinal Center B-Cell Lymphomas
$3,214,174Margaret A Shipp · Dana-Farber Cancer Inst · P01 · FY2007 · CA
Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)
$3,214,086Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health · UM1 · FY2025 · AI
SAN ANTONIO CANCER INSTITUTE
$3,213,782Cancer Therapy And Research Center · P30 · FY2002 · CA
Characterization of Antigen-Specific Immune Response in ALS
$3,213,011Wassim Elyaman · Columbia University Health Sciences · RF1 · FY2025 · NS
SWOG Biospecimen Bank
$3,211,645Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2015 · CA
Therapeutic Index of Acute Lymphoblastic Leukemia
$3,211,219Stephen E Sallan · Dana-Farber Cancer Inst · P01 · FY2007 · CA
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
$3,210,930Nikhil Wagle · Broad Institute, Inc. · U2C · FY2021 · CA
Real-Time Detection of Staphylococcus aureus Transmission in Hospital Settings
$3,210,845Bo Shopsin · New York University School Of Medicine · R01 · FY2025 · AI
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$3,210,574Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2022 · DC
UZCHS CTU
$3,210,348Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2017 · AI
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)
$3,209,830Abhijit Prakash Limaye · University Of California, San Francisco · U01 · FY2025 · AI
Gene Therapy Platform for Rare Diseases
$3,208,999Na Yang · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
COMPREHENSIVE RESOURCES FOR HIV MICROBICIDE AND BIOMEDICAL PREVENTION
$3,208,819James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
The Risks and Opportunities of Homeostatic Repopulation
$3,208,387Stuart Johnston Knechtle · Duke University · U19 · FY2025 · AI
The Risks and Opportunities of Homeostatic Repopulation
$3,208,377Stuart Johnston Knechtle · Duke University · U19 · FY2024 · AI
TCD With Transfusions Changing to Hydroxyurea
$3,207,307Russell E Ware · Cincinnati Childrens Hosp Med Ctr · R01 · FY2013 · HL
22/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Biostatistics Center
$3,207,131Marinella Temprosa · George Washington University · U01 · FY2020 · DK
Stroke with Transfusions Changing to Hydroxyurea
$3,207,047Russell E Ware · St. Jude Children'S Research Hospital · U01 · FY2006 · HL
UZ-UCSF Clinical Trials Unit
$3,206,808Zvavahera Mike Chirenje · University Of California, San Francisco · U01 · FY2007 · AI
Models For Tobacco Product Evaluation
$3,205,996Dorothy K Hatsukami · University Of Minnesota · U19 · FY2013 · CA
Yale Alzheimer Disease Research Center
$3,205,958Stephen M Strittmatter · Yale University · P30 · FY2020 · AG
Task C1: Phase I Clinical Trial to Evaluate Influenza Therapeutics
$3,205,231McClenathan Bruce · Allucent Government Services (Us) Llc · N01 · FY2024 · AI
Genetic Contributions to Phenotypic Heterogeneity in the ALS-FTD Spectrum
$3,204,260Corey T McMillan · University Of Pennsylvania · RF1 · FY2025 · NS